Can-Fite BioPharma Ltd. (CANF)

Oncology Corporate Profile

Stock Performance

1.8500
0.0500

Company Description

Can-Fite BioPharma is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.

Website: http://www.canfite.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CF-102adenosine receptor agonistHepatocellular carcinoma (HCC)II

View additional information on product candidates here »

Source: http://www.canfite.com

Recent News Headlines

7/27/2017 12:18 pm

7/27/2017 12:18 pm

7/27/2017 12:18 pm

7/27/2017 12:18 pm

7/27/2017 12:18 pm

7/17/2017 12:17 am

7/17/2017 12:17 am

7/17/2017 12:17 am

7/17/2017 12:17 am

7/17/2017 12:17 am

6/15/2017 12:17 am

6/15/2017 12:17 am

6/15/2017 12:17 am

6/15/2017 12:17 am

6/15/2017 12:17 am

6/8/2017 12:17 am

6/8/2017 12:17 am

6/8/2017 12:17 am

6/8/2017 12:17 am

6/8/2017 12:17 am

6/5/2017 12:17 am

6/1/2017 12:17 am

5/30/2017 12:17 am

5/16/2017 12:17 am

5/3/2017 12:17 am